The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Mutation in a short-chain collagen gene, CTRP5 , results in extracellular deposit formation in late-onset retinal degeneration: a genetic model for age-related macular degeneration
Abstract
A primary feature of age-related macular degeneration (AMD) is the presence of extracellular deposits between the retinal pigment epithelium (RPE) and underlying Bruch's membrane, leading to RPE dysfunction, photoreceptor death and severe visual loss. AMD accounts for about 50% of blind registrations in Western countries and is a common, genetically complex disorder. Very little is known regarding its molecular basis. Late-onset retinal degeneration (L-ORD) is an autosomal dominant disorder with striking clinical and pathological similarity to AMD. Here we show that L-ORD is genetically heterogeneous and that a proposed founder mutation in the CTRP5 (C1QTNF5) gene, which encodes a novel short-chain collagen, changes a highly conserved serine to arginine (Ser163Arg) in 7/14 L-ORD families and 0/1000 control individuals. The mutation occurs in the gC1q domain of CTRP5 and results in abnormal high molecular weight aggregate formation which may alter its higher-order structure and interactions. These results indicate a novel disease mechanism involving abnormal adhesion between RPE and Bruch's membrane.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A gene (C1QTNF5) mutated in patients with an autosomal dominant late-onset retinal/macular degeneration with sub-RPE deposits similar to AMD has also been examined (68).”
From Unraveling a Multifactorial Late-Onset Disease: From Genetic Susceptibility to Disease Mechanisms for Age-Related Macular Degeneration (2009) · cites this paper as [68]
Citations
Cites
SWISS‐MODEL and the Swiss‐Pdb Viewer: An environment for comparative protein modeling
Guex, N., & Peitsch, M. C. (1997) · Electrophoresis · doi:10.1002/elps.1150181505 · Cited by 11,312
A high-resolution recombination map of the human genome
Kong, A., Gudbjartsson, D. F., Sainz, J., Jonsdottir, G. M., Gudjonsson, S. A., Richardsson, B., Sigurdardottir, S. L., Barnard, J., Hallbeck, B., Másson, G., et al. (2002) · Nature Genetics · doi:10.1038/ng917 · Cited by 1,750
Drusen proteome analysis: an approach to the etiology of age-related macular degeneration
Crabb, J. W., Miyagi, M., Gu, X., Shadrach, K., West, K. A., Sakaguchi, H., Kamei, M., Hasan, A., Yan, L., Rayborn, M. E., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.222551899 · Cited by 1,208
Age-related Macular Degeneration Histopathologic Studies
Green, W. R., & Enger, C. (1993) · Ophthalmology · doi:10.1016/s0161-6420(93)31466-1 · Cited by 757
Qi, J. H., Ebrahem, Q., Moore, N., Murphy, G., Claesson-Welsh, L., Bond, M., Baker, A., & Anand-Apte, B. (2003) · Nature Medicine · doi:10.1038/nm846 · Cited by 658
Weber, B. H. F., Vogt, G., Pruett, R. C., Stöhr, H., & Felbor, U. (1994) · Nature Genetics · doi:10.1038/ng1294-352 · Cited by 656
Shapiro, L. S., & Scherer, P. E. (1998) · Current Biology · doi:10.1016/s0960-9822(98)70133-2 · Cited by 652
Stone, E. M., Lotery, A. J., Munier, F. L., Héon, E., Piguet, B., Guymer, R. H., Vandenburgh, K., Cousin, P., Nishimura, D. Y., Swiderski, R. E., et al. (1999) · Nature Genetics · doi:10.1038/9722 · Cited by 488
C1q: Structure, function, and receptors
Kishore, U., & Reid, K. B. M. (2000) · Immunopharmacology · doi:10.1016/s0162-3109(00)80301-x · Cited by 480
Biswas, S. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.21.2415 · Cited by 394
Research works printed but not linked: 1
- Seddon, J.M. ( 2001 ) Age-related macular degeneration. In Ryan, S.J. (ed.), Retina (3rd edn), Mosby, St Louis, MO, pp. 1039 –1050.
Cited by
Sorted by citations
Dark adaptation and the retinoid cycle of vision
Lamb, T. D., & Pugh, E. N. (2004) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2004.03.001 · Cited by 725
Wenzel, A., Grimm, C., Samardzija, M., & Remé, C. E. (2004) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2004.08.002 · Cited by 655
The dynamic nature of Bruch's membrane
Booij, J. C., Baas, D. C., Beisekeeva, J., Gorgels, T. G. M. F., & Bergen, A. A. B. (2010) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2009.08.003 · Cited by 581
“For at least two of these genes, a corresponding animal model (CTPR5 -/-)[164], Fibl-3[165] showing AMD like features, is available.”
C1q and tumor necrosis factor superfamily: modularity and versatility
Kishore, U., Gaboriaud, C., Waters, P. J., Shrive, A. K., Greenhough, T. J., Reid, K. B. M., Sim, R. B., & Arlaud, G. J. (2004) · Trends in Immunology · doi:10.1016/j.it.2004.08.006 · Cited by 437
Myonectin (CTRP15), a novel myokine that links skeletal muscle to systemic lipid homeostasis
Seldin, M. M., Peterson, J. M., Byerly, M. S., Wei, Z., & Wong, G. W. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.336834 · Cited by 406
“(31), we propose that CTRP5 retains its original designation (20, 33) and CTRP15 retains its current designation as myonectin to prevent confusion in nomenclature.”
BackgroundWong, G. W., Krawczyk, S. A., Kitidis-Mitrokostas, C., Revett, T., Gimeno, R., & Lodish, H. F. (2008) · Biochemical Journal · doi:10.1042/bj20081240 · Cited by 371
Missense Variations in the Fibulin 5 Gene and Age-Related Macular Degeneration
Stone, E. M., Braun, T. A., Russell, S. R., Kuehn, M. H., Lotery, A. J., Moore, P. A., Eastman, C. G., Casavant, T. L., & Sheffield, V. C. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040833 · Cited by 324
Soft Drusen in Age-Related Macular Degeneration: Biology and Targeting Via the Oil Spill Strategies
Curcio, C. A. (2018) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.18-24882 · Cited by 322
CTRP family: linking immunity to metabolism
Schäffler, A., & Buechler, C. (2012) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2011.12.003 · Cited by 305
Adipo-myokines: two sides of the same coin–mediators of inflammation and mediators of exercise
Raschke, S., & Eckel, J. (2013) · Mediators of Inflammation · doi:10.1155/2013/320724 · Cited by 296
Curcio, C. A., Johnson, M., Huang, J.-D., & Rudolf, M. (2009) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2009.08.001 · Cited by 293
“A widespread, thick BlamD associated with mutations of the C1QTNF5 (CTRP5) short-chain collagen gene (Hayward et al., 2003) have abundant EC and UC, apoB immunoreactivity, and linear tracks of contiguous electron-dense solid particles (Milam et al.”
Swaroop, A., Chew, E. Y., Bowes Rickman, C., & Abecasis, G. R. (2009) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev.genom.9.081307.164350 · Cited by 270
“A gene (C1QTNF5) mutated in patients with an autosomal dominant late-onset retinal/macular degeneration with sub-RPE deposits similar to AMD has also been examined (68).”
Self-citationCideciyan, A. V., Alemán, T. S., Świder, M., Schwartz, S., Steinberg, J. D., Brucker, A. J., Maguire, A. M., Bennett, J., Stone, E. M., & Jacobson, S. G. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh048 · Cited by 268
“subject and intra-retinal variation and progression on serial measurements ( 48-50 ).”
BackgroundMethodSelf-citationMetabolic function of the CTRP family of hormones
Seldin, M. M., Tan, S. Y., & Wong, G. W. (2013) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-013-9255-7 · Cited by 249
Physiological role of collagen XVIII and endostatin
Marneros, A. G., & Olsen, B. R. (2005) · The FASEB Journal · doi:10.1096/fj.04-2134rev · Cited by 231
“retinal degeneration, also characterized by abnormal deposits under the RPE (84).”
BackgroundKhan, K. N., Mahroo, O. A., Khan, R. S., Mohamed, M. D., McKibbin, M., Bird, A. C., Michaelides, M., Tufail, A., & Moore, A. T. (2016) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2016.04.008 · Cited by 231
Ghai, R., Waters, P. J., Roumenina, L. T., Gadjeva, M. G., Kojouharova, M. S., Reid, K. B. M., Sim, R. B., & Kishore, U. (2006) · Immunobiology · doi:10.1016/j.imbio.2006.11.001 · Cited by 212
Structural and functional anatomy of the globular domain of complement protein C1q
Kishore, U., Ghai, R., Greenhough, T. J., Shrive, A. K., Bonifati, D. M., Gadjeva, M. G., Waters, P. J., Kojouharova, M. S., Chakraborty, T., & Agrawal, A. C. (2004) · Immunology Letters · doi:10.1016/j.imlet.2004.06.015 · Cited by 197
Extreme hyperopia is the result of null mutations in MFRP , which encodes a Frizzled-related protein
Sundin, O. H., Leppert, G. S., Silva, E. D., Yang, J.-M., Dharmaraj, S., Maumenee, I. H., Santos, L. C., Parsa, C. F., Traboulsi, E. I., Broman, K. W., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501451102 · Cited by 191
Basal deposits and drusen in eyes with age-related maculopathy: Evidence for solid lipid particles
Curcio, C. A., Presley, J. B., Millican, C. L., & Medeiros, N. E. (2005) · Experimental Eye Research · doi:10.1016/j.exer.2004.09.017 · Cited by 171
High-Resolution In Vivo Imaging of the RPE Mosaic in Eyes with Retinal Disease
Roorda, A., Zhang, Y., & Duncan, J. L. (2007) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.06-1450 · Cited by 173
Structure, Function, and Pathology of Bruch's Membrane
Curcio, C. A., & Johnson, M. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4557-0737-9.00020-5 · Cited by 176
A novel adipokine CTRP1 stimulates aldosterone production
Jeon, J. H., Kim, K., Kim, J. H., Baek, A., Cho, H., Lee, Y., Kim, J. W., Kim, D., Han, S. H., Lim, J., et al. (2008) · The FASEB Journal · doi:10.1096/fj.07-9412com · Cited by 167
Wei, Z., Peterson, J. M., Lei, X., Cebotaru, L., Wolfgang, M. J., Baldeviano, G. C., & Wong, G. W. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.303651 · Cited by 164
Bramall, A. N., Wright, A. F., Jacobson, S. G., & McInnes, R. R. (2010) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-060909-153227 · Cited by 152
Self-citationSura, A. A., Chen, L., Messinger, J. D., Swain, T. A., McGwin, G., Freund, K. B., & Curcio, C. A. (2020) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.61.13.19 · Cited by 148
“66,77 Aged monkeys may naturally exhibit soft drusen, but lack BLamD and do not progress to atrophy or NV, 78 suggesting that BLamD is required for drusen that progress.”
Reticular pseudodrusen: A critical phenotype in age-related macular degeneration
Wu, Z., Fletcher, E. L., Kumar, H., Greferath, U., & Guymer, R. H. (2021) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2021.101017 · Cited by 147
Causes and consequences of inherited cone disorders
Roosing, S., Thiadens, A. A. H. J., Hoyng, C. B., Klaver, C. C. W., den Hollander, A. I., & Cremers, F. P. M. (2014) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2014.05.001 · Cited by 147
“It was proposed that mutant CTRP5, which is secreted by the RPE, is unable to fulfill its adhesive property between the RPE and Bruch's membrane (Hayward et al., 2003).”
The R345W mutation in EFEMP1 is pathogenic and causes AMD-like deposits in mice
Fu, L., Garland, D. L., Yang, Z., Shukla, D., Rajendran, A., Pearson, E., Stone, E. M., Zhang, K., & Pierce, E. A. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm198 · Cited by 146
Metabolic Regulation by C1q/TNF-related Protein-13 (CTRP13)
Wei, Z., Peterson, J. M., & Wong, G. W. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.201087 · Cited by 133
Late-Onset Macular Degeneration and Long Anterior Lens Zonules Result from a CTRP5 Gene Mutation
Ayyagari, R., Mandal, M. N. A., Karoukis, A. J., Chen, L., McLaren, N. C., Lichter, M., Wong, D. T., Hitchcock, P. F., Caruso, R. C., Moroi, S. E., et al. (2005) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.05-0159 · Cited by 130
“The macular findings have phenotypic overlap with Sorsby fundus dystrophy,(8) lateonset macular degeneration associated with RDS peripherin gene mutations,(9) age-related macular degeneration (AMD),(10) and late-onset retinal degeneration (L-ORD).(11) Co-occurrence of LAZ with macular degeneration has not been reporte…”
BackgroundMethodResultInfluentialGenetic Variants at 13q12.12 Are Associated with High Myopia in the Han Chinese Population
Shi, Y., Qu, J., Zhang, D., Zhao, P., Zhang, Q., Tam, P. O. S., Sun, L., Zuo, X., Zhou, X., Xiao, X., et al. (2011) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2011.04.022 · Cited by 121
Retinitis Pigmentosa and Allied Disorders
Gregory-Evans, K., Pennesi, M. E., & Weleber, R. G. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4557-0737-9.00040-0 · Cited by 112
Park, S., Choi, J. H., Ryu, H. S., Pak, Y. K., Park, K. S., Lee, H. K., & Lee, W. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.005611 · Cited by 107
Macular dystrophies mimicking age-related macular degeneration
Saksens, N. T. M., Fleckenstein, M., Schmitz-Valckenberg, S., Holz, F. G., den Hollander, A. I., KEUNEN, J. E. E., Boon, C. J. F., & Hoyng, C. B. (2013) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2013.11.001 · Cited by 104
“LORD is a genetically heterogeneous disease with an autosomal-dominant inheritance pattern (Hayward et al., 2003; Kuntz et al., 1996) caused by a heterozygous p.”
BackgroundInfluentialGenetic factors of age-related macular degeneration
Tuo, J., Bojanowski, C. M., & Chan, C. (2004) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2004.02.001 · Cited by 100
“CTRP5 has recently been reported as the causal gene of late-onset retinal degeneration (L-ORD), an autosomal dominant disorder with striking clinical and pathological similarity to AMD (Hayward et al., 2003).”
BackgroundInfluentialLasser, G., Guchhait, P., Ellsworth, J. L., Sheppard, P. O., Lewis, K., Bishop, P. D., Crúz, M. A., López, J. A., & Fruebis, J. (2005) · Blood · doi:10.1182/blood-2005-04-1425 · Cited by 98
Li, Y., Wu, W.-H., Hsu, C.-W., Nguyen, H. V., Tsai, Y., Chan, L., Nagasaki, T., Maumenee, I. H., Yannuzzi, L. A., Hoang, Q. V., et al. (2014) · Molecular Therapy · doi:10.1038/mt.2014.100 · Cited by 84
Dehring, K. A., Smukler, A. R., Roessler, B. J., & Morris, M. D. (2006) · Applied Spectroscopy · doi:10.1366/000370206776593582 · Cited by 82
Mandal, M. N. A., Vasireddy, V., Reddy, G. B., Wang, X., Moroi, S. E., Pattnaik, B. R., Hughes, B. A., Heckenlively, J. R., Hitchcock, P. F., Jablonski, M. M., et al. (2006) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.06-0312 · Cited by 80
“Some of the genes associated with monogenic macular degenerations are expressed in photoreceptors (ELOVL4, RDS, RPGR, ABCA4, and FSCN2) and are thought to have a role in maintaining the structure and/or physiological function of photoreceptor cells.19–23 The remaining genes associated with the macular degenerations ar…”
BackgroundResultInfluentialA New Strategy to Identify and Annotate Human RPE-Specific Gene Expression
Booij, J. C., ten Brink, J. B., Swagemakers, S. M. A., Verkerk, A. J. M. H., Essing, A. H. W., van der Spek, P. J., & Bergen, A. A. B. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009341 · Cited by 78
“C1QTNF5 NM_015645 7 cDNA library, RT-PCR [44,45] 1”
Spatial and Temporal Expression of MFRP and Its Interaction with CTRP5
Mandal, M. N. A., Vasireddy, V., Jablonski, M. M., Wang, X., Heckenlively, J. R., Hughes, B. A., Reddy, G. B., & Ayyagari, R. (2006) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.06-0449 · Cited by 78
“Highest level of expression of Ctrp5 and Mfrp was observed in the RPE and CE, the tissues involved in the pathogenesis of nanophthalmos, recessive retinal degeneration and L-ORD.(6,10,11) In both RPE and CE, we observed colocalization of these proteins (Figs.”
BackgroundMethodRegulation of tissue crosstalk by skeletal muscle-derived myonectin and other myokines
Seldin, M. M., & Wong, G. W. (2012) · Adipocyte · doi:10.4161/adip.20877 · Cited by 69
Gliem, M., Müller, P. L., Birtel, J., Hendig, D., Holz, F. G., & Issa, P. C. (2016) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.16-19388 · Cited by 68
A CTRP5 gene S163R mutation knock-in mouse model for late-onset retinal degeneration
Chavali, V. R. M., Khan, N. W., Cukras, C. A., Bartsch, D., Jablonski, M. M., & Ayyagari, R. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr080 · Cited by 67
“G point mutation (S163R) in the Ctrp5 gene associated with human L-ORD (9).”
BackgroundInfluentialC1qTNF-Related Protein-6 Increases the Expression of Interleukin-10 in Macrophages
Kim, M. J., Lee, W., Park, E., & Park, S. (2010) · Molecules and Cells · doi:10.1007/s10059-010-0088-x · Cited by 68
“…et al., 2005), platelet aggregation (Lasser et al., 2006), chondrogenesis and cartilage development (Maeda et al., 2006), aldosterone pro-duction (Wong et al., 2009), cell proliferation (Akiyama et al., 2007), and extracellular matrix-related functions (Ayyagari et al., 2005; Hayward et al., 2003).”
BackgroundProline metabolism and transport in retinal health and disease
Du, J., Zhu, S., Lim, R. R., & Chao, J. R. (2021) · Amino Acids · doi:10.1007/s00726-021-02981-1 · Cited by 66
Román, A. J., Cideciyan, A. V., Wu, V. F., Garafalo, A. V., & Jacobson, S. G. (2021) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2021.101000 · Cited by 63
Self-citationRatnapriya, R., Zhan, X., Fariss, R. N., Branham, K. E. H., Zipprer, D., Chakarova, C. F., Sergeev, Y. V., Campos, M. M., Othman, M., Friedman, J. S., et al. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu276 · Cited by 66
“Genetic variants in components of the ECM and associated signaling pathways are implicated in early- (TIMP3, EFEMP1) (2) and late- (CTRP5) (19,20) onset inherited macular degeneration as well as in AMD (TIMP3, TGFBR1, COL8A1 and COL10A1) (8,9).”
BackgroundInfluentialSelf-citationLi, C., Chen, J. W., Liu, Z. H., Shen, Y. H., Ding, F. H., Gu, G., Liu, J., Qiu, J. P., Gao, J., Zhang, R., et al. (2018) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2018.09.037 · Cited by 63
Martín-Mérida, I., Aguilera‐Garcia, D., Jose, P. F.-S., Blanco‐Kelly, F., Zurita, O., Almoguera, B., García‐Sandoval, B., Ávila‐Fernández, A., Arteche‐López, A., Mínguez, P., et al. (2018) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.18-23854 · Cited by 61
Yamada, Y., Ichihara, S., Kato, K., Yoshida, T., Yokoi, K., Matsuo, H., Watanabe, S., Metoki, N., Yoshida, H., Satoh, K., et al. (2007) · Journal of Medical Genetics · doi:10.1136/jmg.2007.052415 · Cited by 58
Disease mechanisms in late-onset retinal macular degeneration associated with mutation in C1QTNF5
Shu, X., Tulloch, B., Lennon, A., Vlachantoni, D., Zhou, X., Hayward, C., & Wright, A. F. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl091 · Cited by 57
“The primary antibodies [anti-human C1QTNF5 antibody raised in rabbit immunized with purified thioredoxin fused gC1q domain (10), anti-human MFRP antibody raised in goat immunized with purified recombinant human MFRP C-terminal extracellular domain (R&D Systems, Cat.”
BackgroundInfluentialSelf-citationLate-onset retinal macular degeneration: clinical insights into an inherited retinal degeneration
Borooah, S., Collins, C. E., Wright, A. F., & Dhillon, B. (2008) · Postgraduate Medical Journal · doi:10.1136/bjo.2008.150151 · Cited by 58
“Gross inspection revealed that the deposits are present throughout the retina extending to the ora serrata.”
BackgroundSelf-citationBiswas, L., Zhou, X., Dhillon, B., Graham, A., & Shu, X. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx319 · Cited by 57
Self-citationCellular and Molecular Mechanisms of Pathogenesis Underlying Inherited Retinal Dystrophies
Manley, A., Meshkat, B. I., Jablonski, M. M., & Hollingsworth, T. (2023) · Biomolecules · doi:10.3390/biom13020271 · Cited by 61
Proteomic Landscape of the Human Choroid–Retinal Pigment Epithelial Complex
Skeie, J. M., & Mahajan, V. B. (2014) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2014.2065 · Cited by 56
Lee, W., Kim, M. J., Park, E., Choi, Y., & Park, S. (2010) · FEBS Letters · doi:10.1016/j.febslet.2010.01.040 · Cited by 55
Garland, D. L., Fernández‐Godino, R., Kaur, I., Speicher, K. D., Harnly, J. M., Lambris, J. D., Speicher, D. W., & Pierce, E. A. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt395 · Cited by 54
Won, J., Smith, R. S., Peachey, N. S., WU, J., Hicks, W. L., Naggert, J. Κ., & Nishina, P. M. (2008) · Visual Neuroscience · doi:10.1017/s0952523808080723 · Cited by 53
“It is interesting to note that a mutation in the C1q domain of human C1QTNF5, found in patients with L-ORD (Hayward et al., 2003; Ayyagari et al., 2005), is associated with drusen-like deposits with subsequent retinal degeneration.”
BackgroundLim, S. K., Choi, S. H., Koo, B. K., Kang, S. M., Yoon, J. W., Jang, H. C., Choi, S. M., Lee, M. G., Lee, W., Shin, H., et al. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-1743 · Cited by 52
Expression of a Secretory Protein C1qTNF6, a C1qTNF Family Member, in Hepatocellular Carcinoma
Takeuchi, T., Adachi, Y., & Nagayama, T. (2011) · Analytical Cellular Pathology · doi:10.1155/2011/578097 · Cited by 52
Kim, E. J., Grant, G. R., Bowman, A. S., Haider, N., Gudiseva, H. V., & Chavali, V. R. M. (2018) · Scientific Reports · doi:10.1038/s41598-018-21104-7 · Cited by 53
Wei, Z., Lei, X., Seldin, M. M., & Wong, G. W. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.365965 · Cited by 49
Landowski, M., & Rickman, C. B. (2021) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2021.0067 · Cited by 48
Loss of CTRP5 improves insulin action and hepatic steatosis
Lei, X., Rodriguez, S., Petersen, P. S., Seldin, M. M., Bowman, C. E., Wolfgang, M. J., & Wong, G. W. (2016) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00010.2016 · Cited by 46
Expanding the Clinical and Molecular Heterogeneity of Nonsyndromic Inherited Retinal Dystrophies
Rodríguez‐Muñoz, A., Aller, E., Jaijo, T., García, E. G., Cabrera-Peset, A., Gallego-Pinazo, R., Udaondo, P., Salom, D., García‐García, G., & Millán, J. M. (2020) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2020.01.003 · Cited by 46
Pseudoxanthoma elasticum – Genetics, pathophysiology, and clinical presentation
Pfau, K., Lengyel, I., Norel, J. O., van Leeuwen, R., Risseeuw, S., Lefthériotis, G., Scholl, H. P. N., Feltgen, N., Holz, F. G., & Pfau, M. (2024) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2024.101274 · Cited by 43
“L-ORD is an autosomal-dominant disease due to mutations in the C1QTNF/CTRP5 gene, mainly expressed in the RPE and ciliary epithelium (Ayyagari et al., 2005; Hayward et al., 2003).”
BackgroundDinculescu, A., Estreicher, J., Zenteno, J. C., Alemán, T. S., Schwartz, S., Huang, W., Román, A. J., Sumaroka, A., Li, Q., Deng, W., et al. (2011) · Human Gene Therapy · doi:10.1089/hum.2011.169 · Cited by 43
“CTRP5 also has a human disease association; specifically, a Ser163Arg mutation causes an autosomal dominant late-onset retina-wide degeneration, which can feature neovascular macular degeneration (Milam et al., 2000; Jacobson et al., 2001; Hayward et al., 2003).”
BackgroundSelf-citationLong Anterior Lens Zonules in Late-Onset Retinal Degeneration (L-ORD)
Subrayan, V., Morris, B., Armbrecht, A. M., Wright, A. F., & Dhillon, B. (2005) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2005.06.023 · Cited by 43
Self-citationLONGITUDINAL STRUCTURAL CHANGES IN LATE-ONSET RETINAL DEGENERATION
Cukras, C. A., Flamendorf, J., Wong, W. T., Ayyagari, R., Cunningham, D., & Sieving, P. A. (2016) · Retina · doi:10.1097/iae.0000000000001113 · Cited by 42
Gamal, W., Borooah, S., Smith, S., Underwood, I., Srsen, V., Chandran, S., Bagnaninchi, P., & Dhillon, B. (2015) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2015.04.079 · Cited by 41
“The normal function of C1QTNF5 is currently unknown, however in the eye; it is thought to play a part in interactions between the RPE and the underlying basement membrane since the protein is secreted by the RPE and then attaches to the baso-lateral RPE plasma membrane (Mandal et al., 2006).”
BackgroundInfluentialSelf-citationPhenotypic findings in C1QTNF5 retinopathy (late‐onset retinal degeneration)
Soumplis, V., Sergouniotis, P. I., Robson, A. G., Michaelides, M., Moore, A. T., Holder, G. E., & Webster, A. R. (2013) · Acta Ophthalmologica · doi:10.1111/aos.12010 · Cited by 40
“Importantly, one in two of LORD families carry a p.Ser163Arg mutation in the C1QTNF5 gene (Hayward et al. 2003).”
BackgroundGenetic Associations of Primary Angle-Closure Disease
Rong, S. S., Tang, F. Y., Chu, W. K., Ma, L., Yam, J. C. S., Tang, S. M., Li, J., Gu, H., Young, A. L., Tham, C. C. Y., et al. (2016) · Ophthalmology · doi:10.1016/j.ophtha.2015.12.027 · Cited by 40
Duvvari, M. R., van de Ven, J. P. H., Geerlings, M. J., Saksens, N. T. M., Bakker, B., Henkes, A., Neveling, K., del Rosario, M., Westra, D., van den Heuvel, L. P., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0152047 · Cited by 40
Stanton, C. M., Borooah, S., Drake, C., Marsh, J. A., Campbell, S. E., Lennon, A., Soares, D. C., Vallabh, N. A., Sahni, J., Cideciyan, A. V., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-11898-3 · Cited by 40
Self-citationAMPK modulation ameliorates dominant disease phenotypes of CTRP5 variant in retinal degeneration
Miyagishima, K. J., Sharma, R., Nimmagadda, M., Clore-Gronenborn, K., Qureshy, Z., Ortolan, D., Bose, D., Farnoodian, M., Zhang, C., Fausey, A., et al. (2021) · Communications Biology · doi:10.1038/s42003-021-02872-x · Cited by 43
Loss of Zebrafish Mfrp Causes Nanophthalmia, Hyperopia, and Accumulation of Subretinal Macrophages
Collery, R. F., Volberding, P. J., Bostrom, J. R., Link, B. A., & Besharse, J. C. (2016) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.16-19593 · Cited by 39
Molecular Testing for Hereditary Retinal Disease as Part of Clinical Care
Downs, K. (2007) · Archives of Ophthalmology · doi:10.1001/archopht.125.2.252 · Cited by 39
“A missense mutation, S163R in the C10 tumor necrosis factor–related protein 5 (C1QTNF5/CTRP5) gene, was identified in families with autosomal dominant lateonset retinal degeneration and early-onset abnormal anterior lens zonules.(16,23) Two patients from a large family known to carry the S163R mutation were referred f…”
BackgroundTu, X., & Palczewski, K. (2012) · Journal of Structural Biology · doi:10.1016/j.jsb.2012.07.011 · Cited by 37
“The S163R mutant was shown to be unstable and prone to aggregation (Hayward et al., 2003).”
InfluentialVincent, A., Munier, F. L., VandenHoven, C., Wright, T., Westall, C. A., & Héon, E. (2012) · Retina · doi:10.1097/iae.0b013e318240a574 · Cited by 36
“Late-onset retinal degeneration (LORD) is a rare, fully penetrant, autosomal dominant ocular disease caused by a Ser163Arg mutation in the C1QTNF5 gene.(1) Affected subjects usually first manifest with symptoms of nyctalopia in their forties or later.”
BackgroundLongitudinal adaptive optics fluorescence microscopy reveals cellular mosaicism in patients
Jung, H., Liu, J., Liu, T., George, A., Smelkinson, M. G., Cohen, S., Sharma, R., Schwartz, O., Maminishkis, A., Bharti, K., et al. (2019) · JCI Insight · doi:10.1172/jci.insight.124904 · Cited by 35
Miyadera, K., Kato, K., Boursnell, M. E. G., Mellersh, C. S., & Sargan, D. R. (2011) · Mammalian Genome · doi:10.1007/s00335-011-9384-9 · Cited by 34
“It should be noted that the clinical subgroup LORD defined in the current study is not the direct homolog of the human condition, L-ORD (late-onset retinal degeneration), which has been molecularly characterized (Hayward et al. 2003; Jacobson et al. 2001; Milam et al. 2000).”
Cross, S. H., McKie, L., Hurd, T. W., Riley, S., Wills, J. C., Barnard, A. R., Young, F., MacLaren, R. E., & Jackson, I. J. (2020) · PLoS Genetics · doi:10.1371/journal.pgen.1008583 · Cited by 31
Paraoan, L., Sharif, U., Carlsson, E., Supharattanasitthi, W., Mahmud, N. M., Kamalden, T. A., Hiscott, P. S., Jackson, M. J., & Grierson, I. (2020) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2020.100859 · Cited by 31
Fragiotta, S., Parravano, M., Sacconi, R., Costanzo, E., Viggiano, P., Prascina, F., Capuano, V., Souied, E. H., & Querques, G. (2022) · Retina · doi:10.1097/iae.0000000000003463 · Cited by 32
Kautzmann, M.-A. I., Gordon, W. C., Jun, B., Do, K. V., Matherne, B., Fang, Z., & Bazan, N. G. (2019) · The FASEB Journal · doi:10.1096/fj.201902359r · Cited by 30
Late‐onset retinal degeneration pathology due to mutations in CTRP5 is mediated through HTRA1
Chekuri, A., Zientara‐Rytter, K., Soto‐Hermida, A., Borooah, S., Voronchikhina, M., Biswas, P., Kumar, V., Goodsell, D. S., Hayward, C., Shaw, P. X., et al. (2019) · Aging Cell · doi:10.1111/acel.13011 · Cited by 30
Self-citationRetinitis Pigmentosa and Allied Disorders
Weleber, R. G., & Gregory-Evans, K. (2006) · Elsevier eBooks · doi:10.1016/b978-0-323-02598-0.50023-9 · Cited by 30
Alapati, A. N., Goetz, K., Suk, J. J., Navani, M., Al-Tarouti, A., Jayasundera, T., Tumminia, S. J., Lee, P. L., & Ayyagari, R. (2014) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.14-14359 · Cited by 27
Fleckenstein, M., Graßmann, F., Lindner, M., Pfau, M., Czauderna, J., Strunz, T., von Strachwitz, C. N., Schmitz-Valckenberg, S., Holz, F. G., & Weber, B. H. F. (2016) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.15-18593 · Cited by 27
Soundararajan, R., Won, J., Stearns, T. M., Charette, J. R., Hicks, W. L., Collin, G. B., Naggert, J. Κ., Krebs, M. P., & Nishina, P. M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0110299 · Cited by 25
“Complement C1q tumor necrosis factor–related protein 5 (C1QTNF5, also known as CTRP5) is expressed from the same dicistronic transcript as Mfrp [8,11,15].”
BackgroundLate-Onset Retinal Degeneration Caused byC1QTNF5Mutation
Jacobson, S. G., Cideciyan, A. V., Sumaroka, A., Román, A. J., & Wright, A. F. (2014) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2014.2059 · Cited by 24
Self-citationAntropoli, A., Bianco, L., Romano, F., Trinco, A., Arrigo, A., Benadji, A., Atia, R., Palacci, O., Dagostinoz, D., Devisme, C., et al. (2024) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2024.101320 · Cited by 23
“The first causative variant identified for L-ORD was the founder mutation p.Ser163Arg (Hayward et al., 2003), which remains the most prevalent and extensively studied mutation.”
Yang, W., & Lee, W. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.08.145 · Cited by 22
iPS Cells for Modelling and Treatment of Retinal Diseases
Chen, F. K., McLenachan, S., Edel, M. J., da Cruz, L., Coffey, P. J., & Mackey, D. A. (2014) · Journal of Clinical Medicine · doi:10.3390/jcm3041511 · Cited by 27
“For example: Sorsby fundus dystrophy may be caused by deposition of abnormal extracellular protein (TIMP-3); Doyne honeycomb retinal dystrophy may be related to activation of unfolded protein response due to misfolded fibulin-3 (EFEMP-1); and late-onset retina degeneration may be associated with abnormal intracellular…”
BackgroundHistopathologic-Genotypic Correlations in Retinitis Pigmentosa and Allied Diseases
Ben‐Arie‐Weintrob, Y., Berson, E. L., & Dryja, T. P. (2005) · Ophthalmic Genetics · doi:10.1080/13816810590968032 · Cited by 23
Khan, K. N., Borooah, S., Landó, L., Dans, K., Mahroo, O. A., Meshi, A., Kalitzeos, A. A., Agorogiannis, G., Moghimi, S., Freeman, W. R., et al. (2020) · Translational Vision Science & Technology · doi:10.1167/tvst.9.6.26 · Cited by 23
Almoguera, B., Li, J., Jose, P. F.-S., Liu, Y., March, M., Pellegrino, R., Golhar, R., Cortón, M., Blanco‐Kelly, F., López-Molina, M. I., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0133624 · Cited by 21
“Ser163Arg previously associated with Late-Onset Retinal Degeneration (LORD, #605670) [32] was identified in the index case.”
BackgroundPluripotent Stem Cells to Model Degenerative Retinal Diseases: The RPE Perspective
Dalvi, S., Galloway, C. A., & Singh, R. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-28471-8_1 · Cited by 20
Metadata
- Authors
- Hayward, C., Shu, X., Cideciyan, A. V., Lennon, A., Barran, P., Zareparsi, S., Sawyer, L., Hendry, G., Dhillon, B., Milam, A. H., Luthert, P. J., Swaroop, A., Hastie, N. D., Jacobson, S. G., & Wright, A. F.
- Affiliations
- Western General Hospital (GB)
- University of Pennsylvania (US)
- University of Michigan (US)
- University College London (GB)
- ORCID
- Venue
- Human Molecular Genetics
- Publisher
- Oxford University Press (OUP)
- Published
- 2003-10-15
- Volume
- 12
- Issue
- 20
- Pages
- 2657-2667
- ISSN
- 0964-6906 (ISSN-L)
- 1460-2083
- OpenAlex
- W2101414552
- Cited by
- 191
- References
- 30
- Citations by year
- 2026: 4 · 2025: 9 · 2024: 5 · 2023: 11 · 2022: 6 · 2021: 11 · 2020: 9 · 2019: 8 · 2018: 10 · 2017: 6 · 2016: 10 · 2015: 7 · 2014: 13 · 2013: 5 · 2012: 14
- FWCI
- 8.20
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Human Molecular Genetics (publishedVersion)
- PubMed (publishedVersion)
- ResearchOnline (Glasgow Caledonian University) (acceptedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Funders
- National Eye Institute (EY-13203, EY 13729, U10EY013729, EY13385, R01EY013203, R01EY013385)
- Topics
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Health Sciences › Medicine › Ophthalmology › Retinal Development and Disorders
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Retinal Imaging and Analysis
- Keywords
- CTRP5, late-onset retinal degeneration, age-related macular degeneration, retinal pigment epithelium, Bruch's membrane, founder mutation, genetic heterogeneity, protein aggregation, autosomal dominant inheritance
- MeSH terms
- Aged, Aged, 80 and over, Aging, Amino Acid Sequence, Chromosome Mapping, Collagen, Female, Genetic Markers, Haplotypes, Humans, Immunohistochemistry, Macular Degeneration, Male, Middle Aged, Models, Genetic, Models, Molecular, Molecular Sequence Data, Mutation, Pedigree, Phenotype, Retina, Retinal Degeneration, Time Factors, Blotting, Western, Sequence Homology, Amino Acid, Protein Structure, Tertiary, Age of Onset
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review